TY - JOUR
T1 - Vaccination and allergy: EAACI position paper, practical aspects
AU - Nilsson, Lennart
AU - Brockow, Knut
AU - Alm, Johan
AU - Cardona, Victoria
AU - Caubet, Jean-Christoph
AU - Gomes, Eva
AU - Jenmalm, Maria C.
AU - Lau, Susanne
AU - Netterlid, Eva
AU - Schwarze, Jürgen
AU - Sheikh, Aziz
AU - Storsaeter, Jann
AU - Skevaki, Chrysanthi
AU - Terreehorst, Ingrid
AU - Zanoni, Giovanna
PY - 2017
Y1 - 2017
N2 - Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non-allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine-triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed
AB - Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non-allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine-triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed
U2 - https://doi.org/10.1111/pai.12762
DO - https://doi.org/10.1111/pai.12762
M3 - Review article
C2 - 28779496
SN - 0905-6157
VL - 28
SP - 628
EP - 640
JO - Pediatric allergy and immunology
JF - Pediatric allergy and immunology
IS - 7
ER -